Economic Burden of Gefitinib Versus Pemetrexed for Insured Patients with Lung Cancer in Urban Xinjiang Province, China- A Real World Research
Nov 1, 2016, 00:00
10.1016/j.jval.2016.08.264
https://www.valueinhealthjournal.com/article/S1098-3015(16)30844-0/fulltext
Title :
Economic Burden of Gefitinib Versus Pemetrexed for Insured Patients with Lung Cancer in Urban Xinjiang Province, China- A Real World Research
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30844-0&doi=10.1016/j.jval.2016.08.264
First page :
A887
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2727